Eli Lilly & Co. (LLY)

113.14 +1.40 (1.25%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/23/19 *Est.)
- M&A (3/31/19 *Est)

Latest Headlines

Form 424B3 Elanco Animal Health June 17, 2019 6:56 AM - SEC Filing Form EFFECT Elanco Animal Health June 17, 2019 6:02 AM - SEC Filing Lilly (LLY) Presents Positive Results for Taltz vs. Humira in Head-to-Head Superiority Study in Patients with Active Psoriatic Arthritis at EULAR June 14, 2019 6:46 AM - StreetInsider Lilly Presents Positive Results for Taltz® (ixekizumab) vs. Humira® (adalimumab) in a Head-to-Head (SPIRIT-H2H) Superiority Study in Patients with Active Psoriatic Arthritis at the European Congress June 14, 2019 6:45 AM - PR NewsWire Form S-4/A Elanco Animal Health June 12, 2019 4:08 PM - SEC Filing Lilly (LLY) to Present 5-Year Sustained Efficacy and Safety Results for Taltz in Patients with Plaque Psoriasis at WCD June 11, 2019 6:13 AM - StreetInsider Lilly to Present 5-Year Sustained Efficacy and Safety Results for Taltz® (ixekizumab) in Patients with Plaque Psoriasis at the World Congress of Dermatology June 11, 2019 3:00 AM - PR NewsWire Detailed findings from CAROLINA® outcome trial support long-term cardiovascular safety profile of Tradjenta® June 10, 2019 9:30 PM - PR NewsWire New analysis shows cardiorenal risk reductions of Jardiance® are consistent in adults with type 2 diabetes, cardiovascular disease and kidney disease without overt proteinuria June 10, 2019 1:00 PM - PR NewsWire Eli Lilly & Co. (LLY) Trades Off Worst Level, Still Down 2.8% June 10, 2019 10:28 AM - StreetInsider Trulicity® (dulaglutide) significantly reduced major cardiovascular events for broad range of people with type 2 diabetes June 9, 2019 7:30 PM - PR NewsWire Lilly's ultra rapid lispro provided similar A1C reductions compared to Humalog® (insulin lispro), with superior post-meal blood glucose reductions June 9, 2019 11:30 AM - PR NewsWire Lilly's tirzepatide demonstrates benefits in data presented at the American Diabetes Association's® 79ᵗʰ Scientific Sessions® June 8, 2019 8:30 PM - PR NewsWire Lilly to Present New Data and Commitment to Patient-Centered Solutions at the Annual European Congress of Rheumatology June 6, 2019 6:45 AM - PR NewsWire Form 4 Elanco Animal Health For: Jun 03 Filed by: GARCIA ART A June 5, 2019 4:38 PM - SEC Filing Form 4 Elanco Animal Health For: Jun 03 Filed by: Meer James M June 5, 2019 4:35 PM - SEC Filing Form 4 LILLY ELI & CO For: Jun 05 Filed by: Smiley Joshua L June 5, 2019 2:16 PM - SEC Filing Lilly to Showcase Scientific Innovation within Dermatology Portfolio at 24th World Congress of Dermatology June 5, 2019 6:45 AM - PR NewsWire FDA Approves Emgality® (galcanezumab-gnlm) as the First and Only Medication for the Treatment of Episodic Cluster Headache that Reduces the Frequency of Attacks June 4, 2019 9:01 PM - PR NewsWire FDA approves Lilly's (LLY) treatment for episodic cluster headache that reduces the frequency of attacks June 4, 2019 4:55 PM - StreetInsider Form 4 LILLY ELI & CO For: Jun 03 Filed by: Harrington Michael J June 4, 2019 1:57 PM - SEC Filing Lilly (LLY) Announces FDA Accepts NDA for Triple Combination Tablet for Adults with Type 2 Diabetes June 4, 2019 7:31 AM - StreetInsider U.S. FDA Accepts New Drug Application for Triple Combination Tablet for Adults with Type 2 Diabetes June 4, 2019 7:30 AM - PR NewsWire Eli Lilly & Co. (LLY) Shows Strength, Up 1.3% May 31, 2019 11:19 AM - StreetInsider Hurricane Season is Almost Here. Are You Ready? May 31, 2019 7:00 AM - PR NewsWire Lilly to Participate in Goldman Sachs Global Healthcare Conference May 30, 2019 4:15 PM - PR NewsWire Form S-4 Elanco Animal Health May 30, 2019 8:35 AM - SEC Filing Form EFFECT Elanco Animal Health May 30, 2019 6:02 AM - SEC Filing Lilly Announces Webcast to Discuss ADA Presentations and Diabetes Portfolio May 29, 2019 4:15 PM - PR NewsWire Form 424B3 Elanco Animal Health May 29, 2019 4:10 PM - SEC Filing Lilly (LLY) Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics May 28, 2019 7:55 AM - StreetInsider Lilly Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics May 28, 2019 7:54 AM - PR NewsWire Goldman Sachs Starts Eli Lilly (LLY) at Buy May 28, 2019 2:42 AM - StreetInsider Form 4 LILLY ELI & CO For: May 20 Filed by: Alvarez Ralph May 22, 2019 8:29 AM - SEC Filing Form 4 LILLY ELI & CO For: May 20 Filed by: LUCIANO JUAN R May 22, 2019 8:28 AM - SEC Filing Form 4 LILLY ELI & CO For: May 20 Filed by: TAI JACKSON P May 22, 2019 8:25 AM - SEC Filing Form 4 LILLY ELI & CO For: May 20 Filed by: Walker Karen May 22, 2019 8:23 AM - SEC Filing Lilly (LLY) Says Lower-Priced Insulin is Now Available May 22, 2019 6:38 AM - StreetInsider Lilly's Lower-Priced Insulin Now Available May 22, 2019 6:30 AM - PR NewsWire Eli Lilly & Co. (LLY) Reports Mirikizumab Met Primary Endpoint & Key Secondary Endpoints in Phase 2 Study, Including Reductions of Gastrointestinal Lesions May 21, 2019 1:21 PM - StreetInsider Lilly's Mirikizumab Met Primary Endpoint and Key Secondary Endpoints in Phase 2 Study, Including Reductions of Gastrointestinal Lesions May 21, 2019 1:15 PM - PR NewsWire New Study Suggests Service Dogs Can Impact Psychosocial Health of Household May 21, 2019 7:00 AM - BizWire Form S-4 Elanco Animal Health May 17, 2019 9:31 AM - SEC Filing Form 4/A LILLY ELI & CO For: May 03 Filed by: Shaw Christi May 16, 2019 4:48 PM - SEC Filing Lilly to Participate in UBS Global Healthcare Conference May 16, 2019 4:30 PM - PR NewsWire Form 4 Elanco Animal Health For: May 13 Filed by: BILBREY JOHN P May 15, 2019 5:51 PM - SEC Filing Data Presentations at ASCO 2019 Highlight Lilly's Targeted Approach to Developing Treatments for Patients Living with Cancer May 15, 2019 5:00 PM - PR NewsWire Form 3 Elanco Animal Health For: May 08 Filed by: GARCIA ART A May 15, 2019 7:44 AM - SEC Filing Lilly to Participate in Bank of America Merrill Lynch Health Care Conference May 15, 2019 6:32 AM - PR NewsWire Form 10-Q Elanco Animal Health For: Mar 31 May 14, 2019 4:50 PM - SEC Filing Lilly (LLY) Announces FDA Has Approved CYRAMZA in Patients with HCC May 13, 2019 6:46 AM - StreetInsider Lilly's CYRAMZA® (ramucirumab) Becomes First FDA-Approved Biomarker-Driven Therapy in Patients with Hepatocellular Carcinoma May 13, 2019 6:45 AM - PR NewsWire Form SD LILLY ELI & CO May 9, 2019 12:21 PM - SEC Filing Form 8-K Elanco Animal Health For: May 08 May 9, 2019 8:13 AM - SEC Filing Elanco Animal Health Reports First Quarter Results May 9, 2019 6:29 AM - BizWire Form 8-K LILLY ELI & CO For: May 06 May 8, 2019 4:26 PM - SEC Filing Elanco Appoints Art A. Garcia to Board of Directors May 8, 2019 4:15 PM - BizWire Lilly (LLY) Says Two New Analyses of Lasmiditan Phase 3 Studies Measured Onset of Effect and Effect of Lasmiditan in Patients with Prior Triptan Experience May 8, 2019 6:54 AM - StreetInsider AAN 2019: Two New Analyses of Lasmiditan Phase 3 Studies Measured Onset of Effect and the Effect of Lasmiditan in Patients with Prior Triptan Experience May 8, 2019 6:45 AM - PR NewsWire Form SC 13G Elanco Animal Health Filed by: PRIMECAP MANAGEMENT CO/CA/ May 7, 2019 3:49 PM - SEC Filing Form 4 LILLY ELI & CO For: May 03 Filed by: Shaw Christi May 7, 2019 2:19 PM - SEC Filing Eli Lilly & Co. (LLY) Declares $0.645 Quarterly Dividend; 2.2% Yield May 6, 2019 2:17 PM - StreetInsider Lilly Declares Second-Quarter 2019 Dividend May 6, 2019 2:16 PM - PR NewsWire Lilly (LLY) Presents Results Showing Pooled Analyses of Two Emgality Phase 3 Studies Show Reduction in Monthly Migraine Headache Days May 6, 2019 6:55 AM - StreetInsider AAN 2019: Pooled Analyses of Two Emgality® (galcanezumab-gnlm) Phase 3 Studies Show Reduction in Monthly Migraine Headache Days in Low- and High-Frequency Episodic Migraine Subgroups May 6, 2019 6:45 AM - PR NewsWire Form 4 LILLY ELI & CO For: May 01 Filed by: Shaw Christi May 3, 2019 4:06 PM - SEC Filing Form 10-Q LILLY ELI & CO For: Mar 31 May 2, 2019 2:10 PM - SEC Filing Lilly to Present New Data at AAN 2019 on Emgality® (galcanezumab-gnlm) and Lasmiditan Reinforcing Breadth of Headache Disorders Portfolio May 2, 2019 6:45 AM - PR NewsWire Eli Lilly (LLY) PT Raised to $135 at Wolfe Research May 1, 2019 8:44 AM - StreetInsider Eli Lilly (LLY) PT Raised to $133 at BMO Capital May 1, 2019 7:47 AM - StreetInsider Form 8-K LILLY ELI & CO For: Apr 30 April 30, 2019 1:32 PM - SEC Filing Eli Lilly & Co. (LLY) Tops Q1 EPS by 1c, Offers Guidance April 30, 2019 6:26 AM - StreetInsider Lilly Reports Solid First-Quarter 2019 Financial Results, Updates 2019 Guidance to Reflect Disposition of Elanco Animal Health April 30, 2019 6:25 AM - PR NewsWire Elanco Confirms Date and Conference Call for First Quarter 2019 Financial Results Announcement April 29, 2019 3:30 PM - BizWire Eli Lilly & Co. (LLY) Announces U.S. Court of Appeals Rules in Favor of it in Alimta Vitamin Regimen Patent Lawsuit April 26, 2019 11:29 AM - StreetInsider U.S. Court of Appeals Rules in Favor of Lilly in Alimta Vitamin Regimen Patent Lawsuit April 26, 2019 11:28 AM - PR NewsWire Lilly (LLY) Wins Appeal Upholding Patent on Alimta Drug - Bloomberg April 26, 2019 9:39 AM - StreetInsider Form 8-K Elanco Animal Health For: Apr 26 April 26, 2019 7:07 AM - SEC Filing Elanco Animal Health (ELAN) Reports Agreement to Acquire Aratana Therapeutics; Completes Oncology Development Agreement with VetDC, Creates Specialty Veterinary Business Focus April 26, 2019 6:30 AM - StreetInsider Aratana Therapeutics (PETX) to be Acquired by Elanco Animal Health (ELAN) April 26, 2019 6:29 AM - StreetInsider Elanco Announces Agreement to Acquire Aratana Therapeutics; Completes Oncology Development Agreement with VetDC, Creates Specialty Veterinary Business Focus April 26, 2019 6:29 AM - BizWire Aratana Therapeutics to be Acquired by Elanco Animal Health April 26, 2019 6:28 AM - PR NewsWire Eli Lilly & Co. (LLY) Prepares to Withdraw Lartruvo from Global Market April 25, 2019 6:47 AM - StreetInsider Lilly to Establish an Access Program for Patients as it Prepares to Withdraw Lartruvo from the Global Market April 25, 2019 6:45 AM - PR NewsWire Eli Lilly (LLY) PT Lowered to $120 at Citi April 24, 2019 7:52 AM - StreetInsider Edward Jones Upgrades Eli Lilly (LLy) to Buy April 23, 2019 4:35 PM - StreetInsider BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY) Following Teva's Failure April 23, 2019 10:22 AM - StreetInsider Eli Lilly (LLY) Announces Sale of Legacy Antibiotics Brands and Manufacturing Facility in China (Earlier) April 23, 2019 6:27 AM - StreetInsider Lilly Announces Sale of Legacy Antibiotics Brands and Manufacturing Facility in China April 22, 2019 10:05 PM - PR NewsWire Form DEFA14A LILLY ELI & CO April 22, 2019 2:58 PM - SEC Filing Eli Lilly (LLY) PT Lowered to $130 at BMO Capital But Defending Shares April 22, 2019 7:49 AM - StreetInsider Eli Lilly (LLY) PT Lowered to $131 at UBS April 22, 2019 6:59 AM - StreetInsider Lilly's (LLY) 52-Week Placebo-Controlled Study of Taltz in Patients with nr-axSpA Met Primary Endpoint April 22, 2019 6:48 AM - StreetInsider Lilly Announces Positive Top-Line Results for COAST-X, a 52-Week Placebo-Controlled Study of Taltz® (ixekizumab) in Patients with Non-Radiographic Axial Spondyloarthritis April 22, 2019 6:45 AM - PR NewsWire Eli Lilly & Co. (LLY), Avidity Biosciences Announce Licensing and Research Collaboration April 22, 2019 6:32 AM - StreetInsider Lilly and Avidity Biosciences Announce Licensing and Research Collaboration April 22, 2019 6:30 AM - PR NewsWire Pfizer (PFE). Eli Lilly & Co. (NYSE:LLY) Report Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis April 18, 2019 5:06 PM - StreetInsider Pfizer and Lilly Announce Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis April 18, 2019 5:05 PM - BizWire Merck (MRK), Lilly (LLY), Pfizer (PFE) Weakness Continues as Biotech Shares Get Hit Again April 18, 2019 10:23 AM - StreetInsider Form 4 LILLY ELI & CO For: Apr 15 Filed by: Walker Karen April 17, 2019 3:50 PM - SEC Filing Form 4 LILLY ELI & CO For: Apr 15 Filed by: TAI JACKSON P April 17, 2019 3:46 PM - SEC Filing Form 4 LILLY ELI & CO For: Apr 15 Filed by: MARRAM ELLEN R April 17, 2019 3:42 PM - SEC Filing Form 4 LILLY ELI & CO For: Apr 15 Filed by: LUCIANO JUAN R April 17, 2019 3:36 PM - SEC Filing Form 4 LILLY ELI & CO For: Apr 15 Filed by: Alvarez Ralph April 17, 2019 2:58 PM - SEC Filing Merck (MRK), Pfizer (PFE) Lilly (LLY) Shares Decline Amid Biotech Weakness April 17, 2019 10:26 AM - StreetInsider Form 4 LILLY ELI & CO For: Apr 12 Filed by: Zulueta Alfonso G April 16, 2019 2:48 PM - SEC Filing Form 4 LILLY ELI & CO For: Apr 12 Filed by: Barnes Melissa S April 16, 2019 2:37 PM - SEC Filing Eli Lilly & Co. (LLY) option implied volatility as shares trade near record high April 16, 2019 10:17 AM - StreetInsider Form 4 Elanco Animal Health For: Apr 11 Filed by: Scots-Knight Denise April 12, 2019 5:51 PM - SEC Filing Form 4 Elanco Animal Health For: Apr 11 Filed by: McDonald Kirk P April 12, 2019 5:47 PM - SEC Filing Form 4 Elanco Animal Health For: Apr 11 Filed by: Kurzius Lawrence Erik April 12, 2019 5:44 PM - SEC Filing Form 4 Elanco Animal Health For: Apr 11 Filed by: Kochevar Deborah Turner April 12, 2019 5:40 PM - SEC Filing Form 4 Elanco Animal Health For: Apr 11 Filed by: HOOVER R DAVID April 12, 2019 5:36 PM - SEC Filing Form 4 Elanco Animal Health For: Apr 11 Filed by: Harrington Michael J April 12, 2019 5:32 PM - SEC Filing Form 4 Elanco Animal Health For: Apr 11 Filed by: BILBREY JOHN P April 12, 2019 5:27 PM - SEC Filing Form 4 Elanco Animal Health For: Apr 11 Filed by: Anand Kapila K April 12, 2019 5:24 PM - SEC Filing UPDATE: Guggenheim Downgrades Eli Lilly (LLY) to Neutral April 11, 2019 6:12 AM - StreetInsider Lilly Confirms Date and Conference Call for First-Quarter 2019 Financial Results Announcement April 10, 2019 4:30 PM - PR NewsWire Form SC 13G Elanco Animal Health Filed by: PRICE T ROWE ASSOCIATES INC /MD/ April 10, 2019 1:54 PM - SEC Filing Form 4 LILLY ELI & CO For: Apr 05 Filed by: Shah Aarti S. April 8, 2019 2:55 PM - SEC Filing Form DEF 14A Elanco Animal Health For: May 08 April 3, 2019 4:33 PM - SEC Filing Eli Lilly & Co. (LLY) option implied volatility at low end of 52-week range April 3, 2019 11:06 AM - StreetInsider Form PX14A6G LILLY ELI & CO Filed by: Chevedden John April 2, 2019 10:51 AM - SEC Filing Arteaus Therapeutics Sells Emgality Royalty to Royalty Pharma for $260 Million April 1, 2019 5:00 AM - PR NewsWire Form 4 LILLY ELI & CO For: Mar 26 Filed by: LILLY ENDOWMENT INC March 27, 2019 2:59 PM - SEC Filing Eli Lilly (LLY) PT Raised to $126 at Societe Generale March 27, 2019 1:21 PM - StreetInsider Lilly (LLY) and ImmuNext Announce Licensing and Research Collaboration March 26, 2019 4:30 PM - StreetInsider Lilly and ImmuNext Announce Licensing and Research Collaboration March 26, 2019 4:30 PM - PR NewsWire Form SC 13G Elanco Animal Health Filed by: INTEGRATED CORE STRATEGIES (US) LLC March 25, 2019 5:09 PM - SEC Filing Form 4 LILLY ELI & CO For: Mar 22 Filed by: Zakrowski Donald A March 22, 2019 3:17 PM - SEC Filing Form DEFA14A LILLY ELI & CO March 22, 2019 9:11 AM - SEC Filing Form DEFA14A LILLY ELI & CO March 22, 2019 9:07 AM - SEC Filing Form DEF 14A LILLY ELI & CO For: May 06 March 22, 2019 8:59 AM - SEC Filing Eli Lilly (LLY) PT Raised to $121 at Credit Suisse March 22, 2019 3:56 AM - StreetInsider Eli Lilly (LLY) Upside Source Removed After Alzheimer Trial Discontinuation, Reit $134 PT At BMO March 21, 2019 9:28 AM - StreetInsider Form 3 Elanco Animal Health For: Mar 11 Filed by: Scots-Knight Denise March 20, 2019 6:03 PM - SEC Filing Form 3 Elanco Animal Health For: Mar 11 Filed by: McDonald Kirk P March 20, 2019 5:49 PM - SEC Filing Form 3 Elanco Animal Health For: Mar 11 Filed by: Kochevar Deborah Turner March 20, 2019 5:46 PM - SEC Filing Form 3 Elanco Animal Health For: Mar 11 Filed by: BILBREY JOHN P March 20, 2019 5:38 PM - SEC Filing Form 4 LILLY ELI & CO For: Mar 18 Filed by: Walker Karen March 20, 2019 2:47 PM - SEC Filing Form 4 LILLY ELI & CO For: Mar 18 Filed by: TAI JACKSON P March 20, 2019 2:42 PM - SEC Filing Form 4 LILLY ELI & CO For: Mar 18 Filed by: MARRAM ELLEN R March 20, 2019 2:38 PM - SEC Filing Form 4 LILLY ELI & CO For: Mar 18 Filed by: LUCIANO JUAN R March 20, 2019 2:18 PM - SEC Filing Form 4 LILLY ELI & CO For: Mar 18 Filed by: Alvarez Ralph March 20, 2019 2:11 PM - SEC Filing NCCN Announces Six Quality Improvement Projects in Gastric Cancer Care Approved for Collaboration with Lilly Oncology March 20, 2019 8:45 AM - PR NewsWire Eli Lilly (LLY) PT Raised to $140 at UBS March 20, 2019 7:15 AM - StreetInsider UBS Resumes Eli Lilly (LLY) at Buy March 20, 2019 6:36 AM - StreetInsider Full Article List